Skip to content
MarketScale
‹ Back to IndustriesHealthcare

SandenVendo Announces Integrated Swipe and vīv Mobile Cashless Capabilities

Dallas TX, September 22nd, 2020 – SandenVendo America, a leader in vending machine manufacturing, has announced their V21 machine models now support dual cashless payment capabilities. The ability for SandenVendo machines to support two cashless devices means that operators can promote health and wellness as consumers continue to opt for #TrulyTouchless selection and payment methods at…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
SandenVendo Announces Integrated Swipe and vīv Mobile Cashless Capabilities

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Dallas TX, September 22nd, 2020 – SandenVendo America, a leader in vending machine manufacturing, has announced their V21 machine models now support dual cashless payment capabilities. The ability for SandenVendo machines to support two cashless devices means that operators can promote health and wellness as consumers continue to opt for #TrulyTouchless selection and payment methods at an increasing rate across all unattended retail sale points.

Vice President of Sales & Marketing at SandenVendo America, Joseph Lavook commented, “Now that our machines have dual cashless capabilities we can provide our customers and partners with a way to offer touchless selection and payment options to their accounts without the fear of missing out on traditional swipe, cash and coin sales. We’re proud to be the first major beverage machine manufacturer to enable dual cashless capabilities.”

SandenVendo’s partnership with Vagabond, a leader in modernizing the vending industry, helped address an influx of demand from operators and accounts for Vagabond’s #TrulyTouchless payments platform on beverage machines, which historically have been limited to a single cashless payment device. Installing vīv touchless mobile payment capabilities alongside a traditional credit card reader provides a touchless payment option without impacting the vending operation.

In addition to SandenVendo’s commitment to supporting a clean, safe and #TrulyTouchless purchasing experience, their dual cashless offering facilitates the entire spectrum of vīv’s benefits. Adding vīv increases revenues because the populations of people who prefer either payment method are slightly different. Millennial and Generation Z consumers, who make up well more than half the US workforce, prefer to use cashless mobile apps because they are faster, more secure and already a part of daily life as they order lunch, taxis, or movie tickets.

Further, the addition of vīv helps operators create loyalty with consumers, enables remote price changing, dynamic pricing to boost sales during slow periods, vīv enabled product rebates, and comprehensive consumer engagement — by knowing who is buying what, operators can invite consumers back and begin to optimize planograms to promote high-margin products based on individual preferences.

For more information please reach out to the SandenVendo sales team at 214-765-9066 and info-group.sva@g-sanden.com.

About SandenVendo America

Founded in 1937, SandenVendo America, Inc (https://www.vendoco.com/) is a Dallas, Texas (USA) based manufacturer of commercial refrigeration and heating equipment. We have led the vending and convenience store industries for decades manufacturing some of the world’s best vending machines and foodservice equipment. Stack machines, glass front vendors, hot food displays, refrigerated showcases, ice cream cases, and Micro Market designs, SandenVendo America offers equipment for all of your foodservice needs.

Originally The Vendo Company, a leader in vending manufacturing, SandenVendo America expanded into foodservice equipment in the mid-nineties and began offering micro-market design solutions in 2014. Today, we continue to grow our market share and product lines throughout the world as a wholly-owned subsidiary of Sanden Retail Systems Corporation, Tokyo Japan.

About Vagabond

Vagabond (vgbnd. co) makes technology that modernizes the vending industry. Its operations, communications and payments technologies serve the convenience services industry — businesses that provide vending, food service and related provisions to workplaces.

Operators use Vagabond’s platform for inventory management, product merchandising, service scheduling, truck routing, and financial reconciliation. Vagabond’s IoT network delivers real-time business intelligence to operating teams in the field so they can maximize operating profits. Vagabond’s workplace payments application, called vīv, enables mobile pay at vending machines and convenience markets; order-ahead and delivery at cafeterias and restaurants; and the ordering and fulfillment of office, breakroom and janitorial supplies in the workplace.

This comprehensive commerce platform allows Vagabond to provide data-driven services to consumer packaged goods companies enabling promotion of particular products to individuals in real-time depending on their buying habits. Vagabond powers the convenience services industry by maximizing sales through merchandising, minimizing cost through operational efficiency, establishing new revenue streams for operators, and providing consumers a convenient payment experience.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512